Dietary Supplements Market Research Reports & Industry Analysis
Dietary supplements are regulated by the Food and Drug Administration’s (FDA) Center for Food Safety and Applied Nutrition (CFSAN). Except in the case of a new dietary ingredient, dietary supplements do not need approval by the FDA before being marketed. Under DSHEA, manufacturers must assure that the dietary supplements it manufactures or distributes are safe and that any claims made about them are demonstrated by sufficient data to show that they are not false or misleading.
DSHEA influences the manufacture of dietary supplements by setting forth a number of rules and guidelines. These include: the establishment of a new plan for assuring safety, nutrition and ingredient labeling specifications, outlining directives for marketing literature, regulation for the use of claims and nutritional support statements, and grant to the FDA the authority to establish good manufacturing practice (GMP) regulations.
Dietary Supplements Industry Research & Market Reports
-
Chondroitin Sulfate Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029). The COVID-19 pandemic disrupted the chondroitin sulfate supply chain, making it difficult for companies to obtain the raw materials they needed ... Read More
-
Growth Opportunities in Nutricosmetics Ingredients, Global, 2024–2030
... health and aesthetics through a beauty-from-within approach. It includes supplements as well as functional food and beverages containing health ingredients. Past skinification trends involved a shift of consumers’ focus from cosmetics to actual skin care ... Read More
-
Top 10 Strategic Imperatives in the Nutrition and Wellness Sector, 2024
... that make it difficult to prepare a company for the future. Frost & Sullivan has identified 8 strategic imperatives, as follows: 1. Innovative Business Models 2. Customer Value Chain Compression 3. Transformative Megatrends 4. Disruptive ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400
... will save countless hours of research. Key Findings: Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.) to reach $387,074,915,562 by 2031. Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.), including Average EBITDA, Operating Ratios and ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411
... forecasts that will save countless hours of research. Key Findings: Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $20,249,315,761 by 2031. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.), ... Read More
-
Vitamin, Nutritional Supplement & Other Health-Related Product Manufacturing
... Herbalife Nutrition, Nature's Bounty, and USANA (all based in the US), as well as Arkopharma (France), Nelsons (UK), Tong Ren Tang (China), and divisions of companies such as Pfizer and Procter & Gamble (both based ... Read More
-
Synthetic Antioxidants
... at a CAGR of 6.0% over the analysis period 2023-2030. Liquid Synthetic Antioxidants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.4 Billion by the end ... Read More
-
Chondroitin Sulfate
... at a CAGR of 2.2% over the analysis period 2023-2030. Pharmaceutical Application, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$84.9 Million by the end of ... Read More
-
Natural Beta Carotene
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Food & Beverage End-Use, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$103.4 ... Read More
-
Food Fortifying Agents
... by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. Vitamins, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$38.5 Billion by the ... Read More
-
Vitamin D Therapy
... by 2030, growing at a CAGR of 11.5% over the analysis period 2023-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$5.9 Billion by ... Read More
-
Anti-Aging Agents
... at a CAGR of 6.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$278.9 Million While China is Forecast to Grow at 10.4% CAGR The Anti-Aging Agents market in the U.S. is ... Read More
-
Folic Acid
... at a CAGR of 6.3% over the analysis period 2023-2030. Folic Acid Tablets, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$479.2 Million by the end ... Read More
-
D-Mannose
... of 3.7% over the analysis period 2023-2030. D-Mannose Capsule, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$592.9 Million by the end of the analysis period. ... Read More
-
Feed Premixes
... at a CAGR of 5.8% over the analysis period 2023-2030. Amino Acids Ingredient, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$14.1 Billion by the end ... Read More
-
Natural Antioxidants
... at a CAGR of 5.9% over the analysis period 2023-2030. Vitamin C, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Sodium Butyrate
... at a CAGR of 9.0% over the analysis period 2023-2030. The U.S. Market is Estimated at US$68.3 Million While China is Forecast to Grow at 13.3% CAGR The Sodium Butyrate market in the U.S. is ... Read More
-
Galacto-oligosaccharide (GOS)
... at a CAGR of 6.5% over the analysis period 2023-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$830.9 Million by the ... Read More
-
Synbiotic Products
... at a CAGR of 7.1% over the analysis period 2023-2030. Functional Food & Beverages, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.4 Billion by the ... Read More
-
Vitamin and Mineral Premixes
... reach US$14.3 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Powder Premixes, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach ... Read More
-
Probiotics Dietary Supplements
... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by ... Read More
-
Calcium Butyrate
... at a CAGR of 10.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$77.7 Million While China is Forecast to Grow at 14.0% CAGR The Calcium Butyrate market in the U.S. is ... Read More
-
Mycoprotein
... of 5.7% over the analysis period 2023-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$523.4 Million by the end of the ... Read More
-
Food Amino Acids
... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Glutamic Acid, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$4.4 Billion by ... Read More
-
Synthetic Beta Carotene
... by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Food & Beverage End-Use, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$296.7 ... Read More
Research Assistance
